Anatomic pathology involves the examination of organs, tissues, cells, and bodily fluids to help diagnose and characterize malignancies and other diseases. It plays a vital role in understanding disease processes and pathogenesis. The adoption of anatomic pathology tests and services has increased significantly due to the growing prevalence of chronic and infectious diseases worldwide. The global Anatomic Pathology Market is estimated to be valued at US$ 30.16 Bn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends driving the anatomic pathology market growth is the increasing adoption of immunohistochemistry (IHC) testing. IHC is an important technique in pathology used to identify cell types and biomarkers in tissues. It helps in disease diagnosis and prognosis. The growing application of IHC in disease diagnosis and drug development is contributing to the increased demand for IHC testing globally. Advanced automation and digitization are also improving the efficiency and accuracy of IHC testing, thereby supporting its increased adoption.

Segment Analysis

The global anatomic pathology market can be segmented based on type and product type. By type, the market can be bifurcated into anatomic pathology services and anatomic pathology products. The anatomic pathology services segment currently dominates the market as it provides timely diagnosis and treatment options. By product type, the market can be classified into instruments, consumables, and antibodies. The consumables segment accounts for the largest share of the market owing to the recurring requirement for reagents, probes, and others for tissue processing and slide preparation.

Key Takeaways

The Global Anatomic Pathology Market Size is expected to witness high growth during the forecast period of 2023 to 2030.The North American region currently dominates the global anatomic pathology market owing to advanced healthcare infrastructure and availability of sophisticated diagnostic techniques in countries like the United States and Canada.

Regional analysis:

North America is expected to continue dominating the global anatomic pathology market during the forecast period. This is attributed to factors such as advanced healthcare infrastructure, presence of leading market players, and growing adoption of digital pathology diagnostic solutions in the region. Furthermore, rising strategic collaborations between industry players and healthcare providers is positively impacting the market growth.

Key players:

Key players operating in the anatomic pathology market are Harris Corporation, Airbus Defense and Space, Boeing, Geooptics Inc., Lockheed Martin Corporation, Millennium Space Systems Inc., Northrop Grumman Corporation, OHB AG, OneWeb Ltd, Planet Labs Inc., Sierra Nevada Corporation, Singapore Technologies Engineering Limited, Space Exploration Technologies Corp. (Space X), Surrey Satellite Technology Ltd., and Thales Alenia Space.

Get More Insights Here

https://healthcarelatesteditionnews.blogspot.com/2023/12/the-global-anatomic-pathology-market.html